Admera Health Blog - Admera Health Blog

Pharmacogenomics to Reduce Adverse Drug Events

By Admera Health on Mar 24, 2021 6:08:59 PM

An adverse drug event (ADR) can be defined as an unwanted and harmful side effect of a drug. Adverse drug events are responsible for more than 3.5 million physician office visits, 1 million emergency room visits, and 125,000 hospital admissions. Health care costs associated with ADRs are estimated to be 136 billion dollars annually…

RxVision™: Reviewing New Medications for Gene-Drug and Other Drug Interactions

By Admera Health on Nov 5, 2020 4:09:03 PM

Pharmacogenomics (PGx) is the study of how genes affect a person’s response to drugs. The Admera Health PGxOne™ Plus test is a 60+ gene PGx test that provides insight into drugs for 16+ therapeutic areas, allowing for smarter medication management across multiple medical specialties. In tandem with RxVision™, Admera Health’s dynamic online reporting tool, the PGxOne™ Plus test delivers a complete PGx assessment for patient management solutions…

The PGxOne™ Plus Report: Genetics for Smarter Medication Management

By Admera Health on Oct 13, 2020 11:50:39 PM

Admera Health’s PGxOne™ Plus test pairs robust DNA analysis with clinically insightful gene-drug annotations to provide medically actionable results. Test results are delivered in an easy to read, color-coded report with gene-drug interactions aligning with the FDA’s latest recommendations. In combination with Admera Health’s online portal, RxVision™, the PGxOne™ Plus test provides the most complete PGx assessment available for patient management solutions…

Tuning Into Allele Frequencies

By Elana Silver on Jul 1, 2020 11:02:55 AM

When friends and acquaintances find out that I provide consulting services to genetic testing companies, I’m frequently asked how often people get back a positive result from a genetic test. It’s a loaded question for many reasons. Defining a positive test seems straightforward; it means that the laboratory found a change in a particular gene or chromosome. However, there are many different kinds of genetic tests, and to further complicate matters, how often a certain test result is seen can vary in different populations. I’ll review these issues in more detail below. At its core, the answer to the question can be found in allele frequencies. Allele frequencies show the genetic diversity of a species population – how rich is the gene pool?

Admera Health to Present at Precision Medicine World Conference 2020

By Bridget Pasapane on Jan 16, 2020 10:59:37 AM

Dr. Ruben Bonilla-Guerrero will present in the PMWC 2020 Clinical Diagnostics Showcase for selected organizations, to exhibit their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients…

Treating Chronic Pain Doesn’t Need to be Painful: A Case for Pharmacogenetics

By Admera Health on Sep 30, 2019 10:57:25 AM

Chronic pain is a common reason why people seek medical care and is estimated to affect about 11% to 40% of adults in the United States…

September is National Cholesterol Education Month

By Admera Health on Sep 23, 2019 6:34:32 PM

September is a Time For Back to School, Cooler Temps, Autumn Foliage – and Talking to Your Patients About Their Cholesterol: September is National Cholesterol Education Month…

Autism and PGx: Connecting the Dots

By Admera Health on Apr 30, 2019 2:53:00 PM

Autism Spectrum Disorder (ASD) is a developmental disorder that is characterized by difficulties with speech, non-verbal communication, repetitive behaviors, and social skills. According to the Center of Disease Control, autism affects about 1 out of 59 children in the United States…